{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:39Z","timestamp":1786113039785,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:p>This study aimed to explore the common differentially expressed genes (DEGs) between atherosclerosis (AS) and nonalcoholic fatty liver disease (NAFLD) through bioinformatics. The GSE89632 and GSE100927 datasets from the open-source GEO database were selected for analysis in this study. DEGs between the control and disease groups were identified from the datasets of NAFLD and AS, leading to the identification of genes that are commonly dysregulated in both conditions. Gene set enrichment analysis (GSEA) was performed on 2 datasets, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to investigate the potential biological functions and signaling pathways associated with the common DEGs. A protein\u2013protein interaction network was constructed using the STRING database to identify hub genes. The diagnostic efficacy of these hub genes was evaluated through receiver operating characteristic curve analysis of the GSE63067 and GSE57691 datasets. A total of 45 common DEGs were identified. GSEA indicated that there were common pathways in the GSE89632 and GSE100927 datasets. The GO and KEGG pathway enrichment analyses revealed that the co-expressed genes were mainly enriched in regulating cytokine production, increasing responsiveness to external stimuli, and macrophage activation. The identified signaling pathways primarily included cytokine\u2013cytokine receptor interaction, the toll-like receptor signaling pathway, and the interleukin-17 signaling pathway. Ten hub genes were OSM, IL1B, CCL3, CSF3, IL1RN, TAGLN, CNN1, RGCC, MYH11, and ACTG2. Common DEGs were identified between AS and NAFLD, indicating that these diseases may mutually influence and exacerbate each other during their progression. Exploring their shared pathogenic mechanisms may provide insights into potential therapeutic targets and contribute to the prevention of AS development in patients with NAFLD.<\/jats:p>","DOI":"10.1097\/md.0000000000047035","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:03:22Z","timestamp":1767989002000},"page":"e47035","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the pathogenesis of nonalcoholic fatty liver disease complicated by atherosclerosis via bioinformatics"],"prefix":"10.1097","volume":"105","author":[{"given":"Rui","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Qiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-7738","authenticated-orcid":false,"given":"Guangyao","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/liv.14038","article-title":"Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.","volume":"39","author":"Golabi","year":"2019","journal-title":"Liver Int"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.","volume":"68","author":"Chang","year":"2019","journal-title":"Gut"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jhep.2017.12.012","article-title":"Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study.","volume":"68","author":"Lee","year":"2018","journal-title":"J Hepatol"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis.","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"26805","DOI":"10.1038\/srep26805","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients.","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"l5367","DOI":"10.1136\/bmj.l5367","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cld.2023.01.018","article-title":"Extrahepatic outcomes of nonalcoholic fatty liver disease: cardiovascular diseases.","volume":"27","author":"Armandi","year":"2023","journal-title":"Clin Liver Dis"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14715\/cmb\/2020.66.7.24","article-title":"Identification of atrial fibrillation-related circular RNAs and constructing the integrative regulatory network of circular RNAs, microRNAs and mRNAs by bioinformatics analysis.","volume":"66","author":"Zhai","year":"2020","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"840","DOI":"10.21037\/cdt-19-654","article-title":"Multimodality imaging for the prevention of cardiovascular events: coronary artery calcium and beyond.","volume":"11","author":"Kocyigit","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis.","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2017.05.023","article-title":"Carotid plaque-thickness and common carotid IMT show additive value in cardiovascular risk prediction and reclassification.","volume":"263","author":"Amato","year":"2017","journal-title":"Atherosclerosis"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/CM9.0000000000002753","article-title":"Hypertension and NAFLD risk: insights from the NHANES 2017-2018 and Mendelian randomization analyses.","volume":"137","author":"Yuan","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cgh.2023.09.018","article-title":"Longitudinal outcomes associated with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of 129 studies.","volume":"22","author":"Chan","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"101643","DOI":"10.1016\/j.cpcardiol.2023.101643","article-title":"Cardiovascular morbidity and mortality related to non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"48","author":"Bisaccia","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fphar.2020.00601","article-title":"Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application.","volume":"11","author":"Xu","year":"2020","journal-title":"Front Pharmacol"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.3390\/molecules28196918","article-title":"Glucosamine improves non-alcoholic fatty liver disease induced by high-fat and high-sugar diet through regulating intestinal barrier function, liver inflammation, and lipid metabolism.","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","article-title":"TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.","volume":"21","author":"Zhao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cmet.2024.06.009","article-title":"Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periostin.","volume":"36","author":"Xie","year":"2024","journal-title":"Cell Metab"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/00033197221091317","article-title":"Atherosclerosis and non-alcoholic fatty liver disease.","volume":"73","author":"Balta","year":"2022","journal-title":"Angiology"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"792667","DOI":"10.3389\/fmolb.2021.792667","article-title":"The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease.","volume":"8","author":"Xu","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JIR.S229691","article-title":"Saturated fatty acids in obesity-associated inflammation.","volume":"13","author":"Zhou","year":"2020","journal-title":"J Inflamm Res"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"558525","DOI":"10.3389\/fphar.2020.558525","article-title":"Inulin exerts beneficial effects on non-alcoholic fatty liver disease via modulating gut microbiome and suppressing the lipopolysaccharide-toll-like receptor 4-M\u03c8-nuclear factor-\u03baB-nod-like receptor protein 3 pathway via gut-liver axis in mice.","volume":"11","author":"Bao","year":"2020","journal-title":"Front Pharmacol"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"111180","DOI":"10.1016\/j.foodres.2022.111180","article-title":"Sequentially fermented dealcoholized apple juice intervenes fatty liver induced by high-fat diets via modulation of intestinal flora and gene pathways.","volume":"156","author":"Li","year":"2022","journal-title":"Food Res Int"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"114957","DOI":"10.1016\/j.biopha.2023.114957","article-title":"Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro.","volume":"164","author":"Zheng","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2021.02.124","article-title":"Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD.","volume":"555","author":"Li","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"R27-20260805","first-page":"427","article-title":"Molecular mechanisms in the pathogenesis of metabolically associated fatty liver disease.","volume":"124","author":"Durkovicova","year":"2023","journal-title":"Bratisl Lek Listy"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13040-020-00224-9","article-title":"Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease.","volume":"13","author":"Hu","year":"2020","journal-title":"BioData Min"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/diagnostics12092136","article-title":"Risk predictors of advanced fibrosis in non-alcoholic fatty liver disease.","volume":"12","author":"Olteanu","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"e000543","DOI":"10.1136\/bmjno-2023-000543","article-title":"Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease.","volume":"6","author":"Parikh","year":"2024","journal-title":"BMJ Neurol Open"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jare.2024.05.011","article-title":"ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque.","volume":"70","author":"Zhang","year":"2025","journal-title":"J Adv Res"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/bib\/bby054","article-title":"Trends in the development of miRNA bioinformatics tools.","volume":"20","author":"Chen","year":"2019","journal-title":"Brief Bioinform"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:02:04Z","timestamp":1785949324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047035","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2024-11-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}